These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37950246)

  • 1. CD4
    Liu S; Tao Z; Lou J; Li R; Fu X; Xu J; Wang T; Zhang L; Shang W; Mao Y; Wang F
    J Transl Med; 2023 Nov; 21(1):803. PubMed ID: 37950246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor-infiltrating CCR8
    Chen Q; Shen M; Yan M; Han X; Mu S; Li Y; Li L; Wang Y; Li S; Li T; Wang Y; Wang W; Wei Z; Hu C; Jin A
    J Transl Med; 2024 Jul; 22(1):709. PubMed ID: 39080766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory.
    Kidani Y; Nogami W; Yasumizu Y; Kawashima A; Tanaka A; Sonoda Y; Tona Y; Nashiki K; Matsumoto R; Hagiwara M; Osaki M; Dohi K; Kanazawa T; Ueyama A; Yoshikawa M; Yoshida T; Matsumoto M; Hojo K; Shinonome S; Yoshida H; Hirata M; Haruna M; Nakamura Y; Motooka D; Okuzaki D; Sugiyama Y; Kinoshita M; Okuno T; Kato T; Hatano K; Uemura M; Imamura R; Yokoi K; Tanemura A; Shintani Y; Kimura T; Nonomura N; Wada H; Mori M; Doki Y; Ohkura N; Sakaguchi S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35140181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Prognostic Biomarker CCR8 for Gastric Cancer and Anti-CCR8 Blockade Attenuate the Immunosuppressive Capacity of Tregs
    Zhang Z; Wang G; Shao X; Wu H; Su X; Zhu L; Ji Z
    Cancer Biother Radiopharm; 2023 Aug; 38(6):415-424. PubMed ID: 37102694
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1
    Wang M; Qin Z; Wan J; Yan Y; Duan X; Yao X; Jiang Z; Li W; Qin Z
    Cancer Immunol Immunother; 2022 Nov; 71(11):2717-2730. PubMed ID: 35428909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
    Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
    J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ analysis of CCR8
    Hayashi Y; Ueyama A; Funaki S; Jinushi K; Higuchi N; Morihara H; Hirata M; Nagira Y; Saito T; Kawashima A; Iwahori K; Shintani Y; Wada H
    BMC Cancer; 2024 May; 24(1):627. PubMed ID: 38783281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation of T Helper Cells by Tumor Microenvironment in Oral Cancer Is Associated With CCR8 Expression and Rapid Membrane Vitamin D Signaling Pathway.
    Fraga M; Yáñez M; Sherman M; Llerena F; Hernandez M; Nourdin G; Álvarez F; Urrizola J; Rivera C; Lamperti L; Nova L; Castro S; Zambrano O; Cifuentes A; Campos L; Moya S; Pastor J; Nuñez M; Gatica J; Figueroa J; Zúñiga F; Salomón C; Cerda G; Puentes R; Labarca G; Vidal M; McGregor R; Nova-Lamperti E
    Front Immunol; 2021; 12():643298. PubMed ID: 34025655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
    Wang T; Zhou Q; Zeng H; Zhang H; Liu Z; Shao J; Wang Z; Xiong Y; Wang J; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Chang Y; Wang X; Xu J
    Cancer Immunol Immunother; 2020 Sep; 69(9):1855-1867. PubMed ID: 32367308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.
    Soler D; Chapman TR; Poisson LR; Wang L; Cote-Sierra J; Ryan M; McDonald A; Badola S; Fedyk E; Coyle AJ; Hodge MR; Kolbeck R
    J Immunol; 2006 Nov; 177(10):6940-51. PubMed ID: 17082609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.
    Villarreal DO; L'Huillier A; Armington S; Mottershead C; Filippova EV; Coder BD; Petit RG; Princiotta MF
    Cancer Res; 2018 Sep; 78(18):5340-5348. PubMed ID: 30026324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25- T cells from atopic and nonatopic donors.
    Ahern D; Lloyd CM; Robinson DS
    Allergy; 2009 Aug; 64(8):1121-9. PubMed ID: 19208087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of human CCR8 as a CCL18 receptor.
    Islam SA; Ling MF; Leung J; Shreffler WG; Luster AD
    J Exp Med; 2013 Sep; 210(10):1889-98. PubMed ID: 23999500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
    Iellem A; Mariani M; Lang R; Recalde H; Panina-Bordignon P; Sinigaglia F; D'Ambrosio D
    J Exp Med; 2001 Sep; 194(6):847-53. PubMed ID: 11560999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokine receptor CCR8 is not a high-affinity receptor for the human chemokine CCL18.
    Hussain K; Lim HD; Devkota SR; Kemp-Harper BK; Lane JR; Canals M; Pease JE; Stone MJ
    PLoS One; 2024; 19(9):e0305312. PubMed ID: 39259753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
    Gombert M; Dieu-Nosjean MC; Winterberg F; Bünemann E; Kubitza RC; Da Cunha L; Haahtela A; Lehtimäki S; Müller A; Rieker J; Meller S; Pivarcsi A; Koreck A; Fridman WH; Zentgraf HW; Pavenstädt H; Amara A; Caux C; Kemeny L; Alenius H; Lauerma A; Ruzicka T; Zlotnik A; Homey B
    J Immunol; 2005 Apr; 174(8):5082-91. PubMed ID: 15814739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer.
    Haruna M; Ueyama A; Yamamoto Y; Hirata M; Goto K; Yoshida H; Higuchi N; Yoshida T; Kidani Y; Nakamura Y; Nagira M; Kawashima A; Iwahori K; Shintani Y; Ohkura N; Wada H
    Sci Rep; 2022 Mar; 12(1):5377. PubMed ID: 35354899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody.
    Roider HG; Hoff S; Tseng SY; Berndt S; Trautwein M; Filarsky K; Gritzan U; Camps J; Nadler WM; Grudzinska-Goebel J; Ellinger P; Pesch T; Soon CF; Geyer M; Gluske K; Stelte-Ludwig B; Gorjánácz M
    Clin Exp Med; 2024 Jun; 24(1):122. PubMed ID: 38856863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion.
    Haque NS; Fallon JT; Pan JJ; Taubman MB; Harpel PC
    Blood; 2004 Feb; 103(4):1296-304. PubMed ID: 14576057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR8
    Barsheshet Y; Wildbaum G; Levy E; Vitenshtein A; Akinseye C; Griggs J; Lira SA; Karin N
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6086-6091. PubMed ID: 28533380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.